Radium-223 in mCRPC showed long-term favorable safety, low second primary malignancies/fracture rates, and consistent overall ...

Recent studies show that survival for men with prostate cancer that has spread to the bone is just under two years. But this ...

Dr. Alan Bryce presented the preliminary results from a phase II trial of PT-112 monotherapy in late-line metastatic castration-resistant prostate cancer (mCRPC). Late-line mCRPC patients have poor ...

Exosomes transform prostate cancer care with early detection, tailored treatments, and real-time prognosis tracking for ...

Former US president Joe Biden, 82, has been diagnosed with an “aggressive form” of prostate cancer, and it has spread to his ...

Dr. Kelly Stratton answered the most frequently asked questions in prostate cancer regarding localized prostate cancer care, including surgery and focal therapy.

There were 22 men with progressive mCRPC enrolled, the median age at enrollment was 66 years (range 52-80), the median PSA at original diagnosis was 82 ng/mL (range 5-3,648), 55% had a Gleason score 9 ...

In a post-hoc analysis from the Phase III ARANOTE trial, new results show metastatic castration-sensitive prostate cancer ...

This male cancer can be easily screened for, but the lack of symptoms in the early stages makes it easy to overlook.

Former President Joe Biden said May 30 he is “optimistic” about the treatment plan for his Stage 4 prostate cancer, which ...

Dr Rajesh Kumar Reddy Adapala, Consultant Uro-Oncologist Asian institute of Uro-oncology and Robotic surgery, AINU, Banjara Hills shares with Zee News Digital, the warning signs, risk factors and ...